...AND what progress has been made toward "herd immunity" through exposure in individuals who did not report symptoms or experienced mild symptoms and have no idea that they have already been exposed.
I personally think this divergence in inflammatory cascade will be our economic saving grace, as I believe we are much further along in immunity development than is currently priced into the market.
According to the healthcare company, the test delivers results within 15 minutes from a pinprick with no instrumentation required.
Health care professionals can use the results of the test, along with a patient's medical history, symptoms, and results of other relevant testing, to make informed decisions about patient treatment and care.
Henry Schein said it is working through multiple channels to distribute the tests in the U.S.as quickly as possible due to the urgent need for rapid, accurate testing. The company expects to have at least several hundred thousand tests available by March 30. and significantly increased availability beginning in April 2020.
The Standard Q COVID-19 IgM/IgG Rapid Test is being made available under emergency guidance issued by the U.S. Food and Drug Administration or FDA. It is manufactured by bio-diagnostic company SD Biosensor, Inc., which is represented by VelocityDX in the U.S.